Results 91 to 100 of about 15,859 (208)
Colorectal cancer is a heterogeneous, adaptive disease shaped by population‐level risk, genomic and epigenetic alterations, tumor ecosystem evolution, and treatment pressure. This review integrates epidemiology, risk factors, signaling networks, clinical presentation, screening, molecular diagnosis, and stage‐ and biomarker‐guided management while ...
Kairui Wan +6 more
wiley +1 more source
Background Surgical resection following chemotherapy has been considered a potentially effective strategy for improving survival in patients with stage IV gastric cancer. Recently, the concept of oligometastasis has gained increasing attention. However,
Yota Kawasaki +8 more
core +1 more source
Perspectives in Surgery of Oligometastatic Non-Small-Cell Lung Cancer [PDF]
20-50% of patients with newly diagnosed non-small-cell lung cancer (NSCLC) have synchronous metastases. This dramatically affects survival and traditionally excludes patients from the spectrum of curative therapies.
Stefano Cafarotti +2 more
core
Systematic review and meta-analysis to investigate the incidence, survival, and response outcomes for patients with oligometastatic intracranial metastatic disease (OIMD)
Alyssa Li
core +1 more source
Oligometastatic colorectal adenocarcinoma to the spleen and ovaries. [PDF]
In the context of colorectal cancer, splenic and ovarian metastases are rare outside of widely disseminated disease. Growing evidence suggests that 'oligometastatic' or limited metastatic disease can be treated surgically with good oncological outcomes ...
Yang, T +6 more
core +1 more source
The treatment of oligometastatic disease is challenging and few data exist to guide treatment decisions. The objective of this study was to improve the data on the prevalence and treatment of patients with oligometastatic ...
Galata, Christian +11 more
core +1 more source
Oligometastatic Non-Small Cell Lung Cancer: A Practical Review of Prospective Trials
Oligometastatic non-small cell lung cancer (NSCLC) is an intermediate state between localized and widely metastatic NSCLC, where systemic therapy in combination with aggressive local therapy when feasible can yield a favorable outcome.
Tithi Biswas +5 more
core +1 more source
Role of surgery in oligometastatic prostate cancer
Androgen deprivation therapy as single modality therapy was the standard management for oligometastatic prostate cancer (PCa). Current paradigm shifts toward a multimodality therapy approach, targeting all sites of disease, including treatment of the ...
Pocharapong Jenjitranant +1 more
core +1 more source
Radiation for Oligometastatic Lung Cancer in the Era of Immunotherapy:What Do We (Need to) Know?
Simple Summary The historical standard treatment of metastatic non-small cell lung cancer (NSCLC) consisted of palliative chemotherapy, with limited influence on survival.
Hendriks, Lizza E. L. +7 more
core +1 more source
Background and introduction Increasing evidence suggests that a subgroup of patients with oligometastatic cancer might achieve a prolonged disease-free survival through local therapy for all active cancer lesions.
Sebastian M. Christ +17 more
doaj +1 more source

